Dysfunction
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Intraoperative Ketamine Versus Lidocaine Infusion on Postoperative Cognitive Dysfunction in Patients Undergoing Hip Surgery
Effect of Kinetic Control Exercise on Shoulder Dysfunction Post Mastectomy
Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors
Effectiveness of a Physical Recovery Program for Head and Neck Cancer Patients (3C-CUIDATE)
Normal Range of TSH and FT4 in Pregnancy
Strength and Strength-ratio of Hip Rotator Muscles at Soccer Players